Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Cell migration/invasion assays and their application in cancer drug discovery.

Eccles SA, Box C, Court W.

Biotechnol Annu Rev. 2005;11:391-421. Review.

PMID:
16216785
2.

Two-dimensional vs. three-dimensional in vitro tumor migration and invasion assays.

Zimmermann M, Box C, Eccles SA.

Methods Mol Biol. 2013;986:227-52. doi: 10.1007/978-1-62703-311-4_15.

PMID:
23436416
3.

[Screening for the inhibitors of tumor invasion into basement membranes].

Saiki I.

Gan To Kagaku Ryoho. 1997 Jan;24(2):187-95. Review. Japanese.

PMID:
9030229
4.

Tumour invasion and metastasis: challenges facing drug discovery.

Elvin P, Garner AP.

Curr Opin Pharmacol. 2005 Aug;5(4):374-81. Review.

PMID:
15955738
5.

A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors.

Saito K, Oku T, Ata N, Miyashiro H, Hattori M, Saiki I.

Biol Pharm Bull. 1997 Apr;20(4):345-8.

PMID:
9145207
6.
7.

Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.

Prestwich GD.

Acc Chem Res. 2008 Jan;41(1):139-48. Epub 2007 Jul 27. Review.

PMID:
17655274
8.

[Screening for inhibitors of tumor invasion into basement membranes].

Saiki I.

Gan To Kagaku Ryoho. 2004 Apr;31(4):512-7. Japanese.

PMID:
15114692
9.

Molecular mechanisms of cancer cell invasion and plasticity.

Wolf K, Friedl P.

Br J Dermatol. 2006 May;154 Suppl 1:11-5. Review.

PMID:
16712711
10.
11.

Mechanisms of cancer cell invasion.

Sahai E.

Curr Opin Genet Dev. 2005 Feb;15(1):87-96. Review.

PMID:
15661538
12.

Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation.

Shin KD, Lee MY, Shin DS, Lee S, Son KH, Koh S, Paik YK, Kwon BM, Han DC.

J Biol Chem. 2005 Dec 16;280(50):41439-48. Epub 2005 Oct 18.

13.

Antiprotease therapy in cancer: hot or not?

Lah TT, DurĂ¡n Alonso MB, Van Noorden CJ.

Expert Opin Biol Ther. 2006 Mar;6(3):257-79. Review.

PMID:
16503735
14.

The metastatic process: methodological advances and pharmacological challenges.

Mazzocca A, Carloni V.

Curr Med Chem. 2009;16(14):1704-17. Review.

PMID:
19442141
15.

[The sodium pump could constitute a new target to combat glioblastomas].

Lefranc F, Mijatovic T, Kiss R.

Bull Cancer. 2008 Mar;95(3):271-81. doi: 10.1684/bdc.2008.0597. French.

PMID:
18390407
16.

Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.

Shin DH, Kim JH, Jung YJ, Kim KE, Jeong JM, Chun YS, Park JW.

Cancer Lett. 2007 Sep 18;255(1):107-16. Epub 2007 May 14.

PMID:
17502124
17.

Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).

Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC, Chung JG.

Cancer Lett. 2009 Nov 28;285(2):127-33. doi: 10.1016/j.canlet.2009.04.037. Epub 2009 May 23.

PMID:
19477063
18.

Invasion and metastasis.

Carr I, Orr FW.

Can Med Assoc J. 1983 May 15;128(10):1164-7.

19.

The tumour microenvironment: a novel target for cancer therapy.

Hanna E, Quick J, Libutti SK.

Oral Dis. 2009 Jan;15(1):8-17. doi: 10.1111/j.1601-0825.2008.01471.x. Epub 2008 Nov 1. Review.

PMID:
18992016
20.

Neurotransmitters and chemokines regulate tumor cell migration: potential for a new pharmacological approach to inhibit invasion and metastasis development.

Entschladen F, Drell TL 4th, Lang K, Joseph J, Zaenker KS.

Curr Pharm Des. 2005;11(3):403-11. Review.

PMID:
15723634
Items per page

Supplemental Content

Write to the Help Desk